The global Electronic Data Capture (EDC) systems market size was valued at USD 349.8 million in 2016. The increasing complexity in management of clinical information generated before, during, and after the trial is expected to propel demand for EDC system over the forecast period. The statistics published by the Center for Study of Drug Development states that more than 80% of clinical trials failed as they are unable to meet regulatory requirements, which resulted in delayed drug commercialization. This resulted in loss of revenue for manufacturers. EDC systems help curb this problem by capturing & managing the clinical information in a simple way.
The companies are investing toimplement eClinical solutions in order to manage clinical data because ofthe benefits attached with it, such as ease of use, integration of multiple functions, remote access to information, and cost saving. The aforementioned factors are anticipated to boost the adoption of EDC in coming years.
U.S. EDC systems market, by component, 2014 - 2025 (USD Million)
Services for the EDC systems held the largest market share as of 2016, owing to the availability of a large number of Contract Research Organizations (CROs) offering the eClinical solutions. This is due to the increasing scrutiny from regulatory bodies to meet the complex regulatory requirements of clinical trials, which is anticipated to contribute toward the growing demand over the forecast period.
Software segment is anticipated to witness lucrative growth in near future due to rising adoption by manufacturers to curb growing expenditure on data management. The associated benefits of using EDC systems, such as timesaving and simpler regulatory processes, are presumed to boost the adoption in coming years.
Depending on the current level of implementation and future growth prospects, cloud-based delivery systems for EDC servicesare expected to register the highest demand in near future. This exponential growth rate is a consequence of increasingly being recognized to provide greater efficiency in numerous applications, such as the trial design stage, data collection processes, and monitoring & report generation.
On the other hand, web-based portal holds the largest share in the delivery mode segment, owing to the high data maintenance cost involved in clinical trials, which has increased dramatically. These high costs are presumed to contribute to the high reluctance of pharmaceutical companies, thus restricting them to invest in expensive studies and focus on relatively inexpensive alternatives for information management, such as web-based portals.
In the development phase segment, Phase III held a substantial share in 2016 owing to the high requirement for EDC software in order to curb the overall cost and improve the efficiency of processes. On the other hand, Phase I is presumed to grow with a lucrative growth rate in the near future as a consequence of high significance of these systems in predicting the future outcomes and eliminating drug candidateswith low probability of success in the clinical trials.
A large number of phase I trials and complex management and analysis processes of the information acquired during various studies have been boosting the demand for the computer-assisted solutions. The currently available tools have enabled minimization of manual errors and have increased the efficiency by cutting huge costs incurred through bypassing the processes of manual sourcing, transcribing, and double data entry. Direct data and remote information capturing are the factors aiding the rising popularity of these components during the forecast period. Integration of EDC systems is expected to result in lowering of the prices for data management, which is anticipated to boost the market in the developing regions.
CROs held the largest market share and are anticipated to exhibit the fastest growth as a consequence of rising inclination of pharmaceutical companies toward reducing overall expenditure and involved benefits, which are anticipated to be responsible for the heightened growth.
The benefits primarily include cost-effectiveness, increased efficiency of services, enhanced compatibility, and a higher focus on the core areas of development that are critical to a company's growth. Clinical information management involves clinical data processing by using a range of computer applications and support services.
Global EDC systems market share, by end use, 2016 (%)
North America held the largest market share as of 2016 owing to the presence of higher awareness levels and stringent regulatory norms pertaining to the handling of clinical information. In addition, the presence of major pharmaceutical companies in this region is anticipated to boost the adoption of EDC systems over the forecast period.
Asia Pacific market for EDC systems is presumed to witness lucrative growth in near future due to the presence of a large number of CROs offering eClinical solutions to large pharmaceutical companies.
Some of the key players operating in this industry are Medidata Solutions, Inc.; Oracle Corporation; BioClinica; Parexel International Corporation; Datatrak International, Inc.; Medidata Solutions, Inc.; eClinicalSolutions; Merge Healthcare, Inc.; OmniComm Systems, Inc.; Acceliant; Clinipace, Inc.; and Openclinica, LLC.
Oracle Corporation and Medidata solutions are the most notable market players accounting for a considerable share of the market owing to their productofferings. Market leaders are involved in extensive research forthe development of cost-effective and highly technologically advanced products. Subsequently, introduction of such efficient products is expected to provide this industry with potential growth opportunities.
|
Attribute |
Details |
|
Base year for estimation |
2016 |
|
Actual estimates/Historical data |
2014 - 2016 |
|
Forecast period |
2017 - 2025 |
|
Market representation |
Revenue in USD Million and CAGR from 2017 to 2025 |
|
Regional scope |
North America, Europe, Asia-Pacific, Latin America & MEA |
|
Country scope |
U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa, Saudi Arabia |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
|
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth and provides an analysis of the industrytrends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the EDC Systems market on the basis of the component, delivery mode, development phase, end-use, and region:
Software
Services
Web hosted
Licensed eterprise
Cloud based
Phase I
Phase II
Phase III
Phase IV
Hospitals
CROs
Academic institutes
Pharma & Biotech Organizations
Medical Device Manufacturers
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
Saudi Arabia
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
